Abstract
This clinical case presents a 55-year-old man with a locally-advanced malignant kidney tumor. The patient receives a radical nephrectomy and adjuvant pembrolizumab. The patient develops hypereosinophilia with organ-specific kidney injury. By means of applying the Naranjo test, we concluded that this adverse event was caused by immunotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have